HEADER TOXIN/IMMUNE SYSTEM 25-SEP-14 4V1D TITLE TERNARY COMPLEX AMONG TWO HUMAN DERIVED SINGLE CHAIN ANTIBODY TITLE 2 FRAGMENTS AND CN2 TOXIN FROM SCORPION CENTRUROIDES NOXIUS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: BETA-MAMMAL TOXIN CN2; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: UNP RESIDUES 17-82; COMPND 13 SYNONYM: TOXIN 2, TOXIN II.9.2.2; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN; COMPND 16 CHAIN: D; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN; COMPND 20 CHAIN: E; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TG1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PSYN; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PSYN1; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 19 EXPRESSION_SYSTEM_VARIANT: TG1; SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_VECTOR: PSYN; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PSYN1; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: CENTRUROIDES NOXIUS; SOURCE 25 ORGANISM_COMMON: MEXICAN SCORPION; SOURCE 26 ORGANISM_TAXID: 6878; SOURCE 27 MOL_ID: 4; SOURCE 28 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 29 ORGANISM_COMMON: HUMAN; SOURCE 30 ORGANISM_TAXID: 9606; SOURCE 31 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 32 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 33 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 34 EXPRESSION_SYSTEM_VARIANT: TG1; SOURCE 35 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 36 EXPRESSION_SYSTEM_VECTOR: PSYN; SOURCE 37 EXPRESSION_SYSTEM_PLASMID: PSYN1; SOURCE 38 MOL_ID: 5; SOURCE 39 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 40 ORGANISM_COMMON: HUMAN; SOURCE 41 ORGANISM_TAXID: 9606; SOURCE 42 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 43 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 44 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 45 EXPRESSION_SYSTEM_VARIANT: TG1; SOURCE 46 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 47 EXPRESSION_SYSTEM_VECTOR: PSYN; SOURCE 48 EXPRESSION_SYSTEM_PLASMID: PSYN1 KEYWDS TOXIN-IMMUNE SYSTEM COMPLEX, HUMAN SCFV, SCORPION VENOM KEYWDS 2 NEUTRALIZATION, DIRECTED EVOLUTION, CN2 TOXIN. EXPDTA X-RAY DIFFRACTION AUTHOR L.RIANO-UMBARILA,H.SERRANO-POSADA,S.ROJAS-TREJO,E.RUDINO-PINERA, AUTHOR 2 B.BECERRIL REVDAT 4 10-JAN-24 4V1D 1 REMARK REVDAT 3 03-FEB-16 4V1D 1 JRNL REVDAT 2 09-DEC-15 4V1D 1 JRNL REVDAT 1 07-OCT-15 4V1D 0 JRNL AUTH L.RIANO-UMBARILA,L.M.LEDEZMA-CANDANOZA,H.SERRANO-POSADA, JRNL AUTH 2 G.FERNANDEZ-TABOADA,T.OLAMENDI-PORTUGAL,S.ROJAS-TREJO, JRNL AUTH 3 I.V.GOMEZ-RAMIREZ,E.RUDINO-PINERA,L.D.POSSANI,B.BECERRIL JRNL TITL OPTIMAL NEUTRALIZATION OF CENTRUROIDES NOXIUS VENOM IS JRNL TITL 2 UNDERSTOOD THROUGH A STRUCTURAL COMPLEX BETWEEN TWO ANTIBODY JRNL TITL 3 FRAGMENTS AND THE CN2 TOXIN. JRNL REF J.BIOL.CHEM. V. 291 1619 2016 JRNL REFN ISSN 0021-9258 JRNL PMID 26589800 JRNL DOI 10.1074/JBC.M115.685297 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.910 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 9184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.2164 - 4.4694 1.00 3000 169 0.1733 0.2093 REMARK 3 2 4.4694 - 3.5483 1.00 2885 137 0.1757 0.2255 REMARK 3 3 3.5483 - 3.1000 1.00 2860 133 0.2180 0.2735 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.070 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4142 REMARK 3 ANGLE : 1.124 5599 REMARK 3 CHIRALITY : 0.047 590 REMARK 3 PLANARITY : 0.004 731 REMARK 3 DIHEDRAL : 14.505 1478 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4V1D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1290061796. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : DOUBLE CRYSTAL CHANNEL CUT, REMARK 200 SI(111), 1M LONG RH COATED REMARK 200 TOROIDAL MIRROR FOR VERTICAL AND REMARK 200 HORIZONTAL FOCUSING. REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9184 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 39.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 9.80 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2YC1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SPG PH 8.5, 25%(W/V) PEG 1500 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.32150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.11950 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.32150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 70.11950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 118 REMARK 465 GLY B 119 REMARK 465 GLY B 120 REMARK 465 GLY B 121 REMARK 465 SER B 122 REMARK 465 GLY B 123 REMARK 465 GLY B 124 REMARK 465 GLY B 125 REMARK 465 GLY B 126 REMARK 465 SER B 127 REMARK 465 GLY B 128 REMARK 465 GLY B 129 REMARK 465 GLY B 130 REMARK 465 GLY B 131 REMARK 465 ALA B 241 REMARK 465 ALA B 242 REMARK 465 ALA B 243 REMARK 465 GLU B 244 REMARK 465 GLN B 245 REMARK 465 LYS B 246 REMARK 465 LEU B 247 REMARK 465 ILE B 248 REMARK 465 SER B 249 REMARK 465 GLU B 250 REMARK 465 GLU B 251 REMARK 465 ASP B 252 REMARK 465 LEU B 253 REMARK 465 ASN B 254 REMARK 465 GLY B 255 REMARK 465 ALA B 256 REMARK 465 ALA B 257 REMARK 465 HIS B 258 REMARK 465 HIS B 259 REMARK 465 HIS B 260 REMARK 465 HIS B 261 REMARK 465 HIS B 262 REMARK 465 HIS B 263 REMARK 465 GLY E 125 REMARK 465 GLY E 126 REMARK 465 GLY E 127 REMARK 465 GLY E 128 REMARK 465 SER E 129 REMARK 465 GLY E 130 REMARK 465 GLY E 131 REMARK 465 GLY E 132 REMARK 465 GLY E 133 REMARK 465 SER E 134 REMARK 465 GLY E 135 REMARK 465 GLY E 136 REMARK 465 GLY E 137 REMARK 465 GLY E 138 REMARK 465 ALA E 251 REMARK 465 ALA E 252 REMARK 465 ALA E 253 REMARK 465 GLU E 254 REMARK 465 GLN E 255 REMARK 465 LYS E 256 REMARK 465 LEU E 257 REMARK 465 ILE E 258 REMARK 465 SER E 259 REMARK 465 GLU E 260 REMARK 465 GLU E 261 REMARK 465 ASP E 262 REMARK 465 LEU E 263 REMARK 465 ASN E 264 REMARK 465 GLY E 265 REMARK 465 ALA E 266 REMARK 465 ALA E 267 REMARK 465 HIS E 268 REMARK 465 HIS E 269 REMARK 465 HIS E 270 REMARK 465 HIS E 271 REMARK 465 HIS E 272 REMARK 465 HIS E 273 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 240 CA C O CB CG CD NE REMARK 470 ARG B 240 CZ NH1 NH2 REMARK 470 SER C 66 CA C O CB OG REMARK 470 GLY E 250 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB CYS C 12 SG CYS C 65 1.30 REMARK 500 ND2 ASN C 62 OG SER E 234 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLY B 148 OG SER D 17 2667 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 92 165.53 174.68 REMARK 500 ARG B 162 -120.80 48.97 REMARK 500 ALA B 183 -39.23 70.42 REMARK 500 VAL D 48 -62.96 -98.84 REMARK 500 ARG D 101 -169.48 -160.78 REMARK 500 SER E 166 -10.45 86.42 REMARK 500 ASN E 167 -72.25 -124.64 REMARK 500 SER E 170 -59.58 -127.88 REMARK 500 LEU E 187 -61.59 -93.06 REMARK 500 SER E 190 73.14 40.73 REMARK 500 ASN E 192 167.83 176.28 REMARK 500 ARG E 194 165.44 55.45 REMARK 500 SER E 196 -119.88 63.94 REMARK 500 VAL E 198 54.69 -144.42 REMARK 500 PRO E 199 1.32 -59.09 REMARK 500 ASP E 200 -128.29 65.74 REMARK 500 ARG E 201 -19.94 64.50 REMARK 500 ASP E 208 -114.91 51.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG E 194 PRO E 195 147.35 REMARK 500 PRO E 199 ASP E 200 -149.29 REMARK 500 ASP E 233 SER E 234 147.66 REMARK 500 REMARK 500 REMARK: NULL DBREF 4V1D A 1 117 PDB 4V1D 4V1D 1 117 DBREF 4V1D B 118 263 PDB 4V1D 4V1D 118 263 DBREF 4V1D C 1 66 UNP P01495 SCX2_CENNO 17 82 DBREF 4V1D D 1 124 PDB 4V1D 4V1D 1 124 DBREF 4V1D E 125 273 PDB 4V1D 4V1D 125 273 SEQRES 1 A 117 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 A 117 PRO GLY GLY SER LEU ARG LEU SER CYS THR GLY SER GLY SEQRES 3 A 117 PHE THR PHE ASP ASN TYR ALA MET HIS TRP LEU ARG GLN SEQRES 4 A 117 VAL PRO GLY GLU GLY LEU GLU TRP VAL SER GLY ILE SER SEQRES 5 A 117 ARG SER SER GLY ASP ILE ASP TYR ALA ASP SER VAL LYS SEQRES 6 A 117 GLY ARG PHE THR ILE SER ARG ASP ASP ALA LYS LYS THR SEQRES 7 A 117 LEU SER LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 A 117 ALA VAL TYR TYR CYS ALA ARG GLY GLY PHE GLY SER PHE SEQRES 9 A 117 ASP THR TRP GLY GLN GLY THR MET VAL THR VAL SER SER SEQRES 1 B 146 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY SEQRES 2 B 146 GLY SER GLU ILE VAL LEU THR GLN SER PRO ALA THR LEU SEQRES 3 B 146 SER VAL SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG SEQRES 4 B 146 ALA SER GLN SER VAL ARG SER TYR LEU ALA TRP TYR GLN SEQRES 5 B 146 GLN LYS PRO GLY GLN ALA PRO ARG LEU LEU PHE SER ASP SEQRES 6 B 146 ALA SER ASN ARG ALA THR GLY ILE PRO ALA ARG PHE THR SEQRES 7 B 146 GLY SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER SEQRES 8 B 146 SER LEU GLU PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN SEQRES 9 B 146 GLN TYR ARG TYR SER PRO ARG THR PHE GLY GLN GLY THR SEQRES 10 B 146 LYS VAL GLU ILE LYS ARG ALA ALA ALA GLU GLN LYS LEU SEQRES 11 B 146 ILE SER GLU GLU ASP LEU ASN GLY ALA ALA HIS HIS HIS SEQRES 12 B 146 HIS HIS HIS SEQRES 1 C 66 LYS GLU GLY TYR LEU VAL ASP LYS ASN THR GLY CYS LYS SEQRES 2 C 66 TYR GLU CYS LEU LYS LEU GLY ASP ASN ASP TYR CYS LEU SEQRES 3 C 66 ARG GLU CYS LYS GLN GLN TYR GLY LYS GLY ALA GLY GLY SEQRES 4 C 66 TYR CYS TYR ALA PHE ALA CYS TRP CYS THR HIS LEU TYR SEQRES 5 C 66 GLU GLN ALA ILE VAL TRP PRO LEU PRO ASN LYS ARG CYS SEQRES 6 C 66 SER SEQRES 1 D 124 GLN VAL ASN LEU ARG GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 D 124 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 D 124 PHE SER PHE GLY SER TYR GLY MET HIS TRP VAL ARG GLN SEQRES 4 D 124 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL ILE SER SEQRES 5 D 124 TYR GLY GLY GLY ASN LYS TYR TYR ALA ASP SER VAL LYS SEQRES 6 D 124 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 D 124 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 D 124 ALA VAL TYR TYR CYS ALA LYS ASP ALA ARG ASP CYS LEU SEQRES 9 D 124 LEU CYS ALA ASP TRP HIS PHE ASP LEU TRP GLY ARG GLY SEQRES 10 D 124 THR LEU VAL THR VAL SER SER SEQRES 1 E 149 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY SEQRES 2 E 149 GLY SER ASN PHE MET LEU THR GLN PRO HIS SER ALA SER SEQRES 3 E 149 GLY THR PRO GLY GLN ARG VAL THR ILE SER CYS SER GLY SEQRES 4 E 149 SER SER SER ASN ILE GLY SER ASN THR VAL ASN TRP TYR SEQRES 5 E 149 ARG HIS LEU PRO GLY SER ALA PRO GLU LEU LEU ILE GLY SEQRES 6 E 149 SER HIS ASN GLN ARG PRO SER GLY VAL PRO ASP ARG PHE SEQRES 7 E 149 SER ALA SER LYS SER ASP THR SER ALA SER LEU ALA ILE SEQRES 8 E 149 SER GLY LEU GLN SER GLU ASP GLU ALA ASP TYR TYR CYS SEQRES 9 E 149 ALA ALA TRP ASP ASP SER LEU ILE GLY TYR VAL PHE GLY SEQRES 10 E 149 THR GLY THR LYS LEU THR VAL LEU GLY ALA ALA ALA GLU SEQRES 11 E 149 GLN LYS LEU ILE SER GLU GLU ASP LEU ASN GLY ALA ALA SEQRES 12 E 149 HIS HIS HIS HIS HIS HIS FORMUL 6 HOH *6(H2 O) HELIX 1 1 THR A 28 TYR A 32 5 5 HELIX 2 2 ARG A 53 GLY A 56 5 4 HELIX 3 3 ASP A 62 LYS A 65 5 4 HELIX 4 4 ARG A 87 THR A 91 5 5 HELIX 5 5 GLU B 211 PHE B 215 5 5 HELIX 6 6 ASN C 22 GLY C 34 1 13 HELIX 7 7 SER D 28 TYR D 32 5 5 HELIX 8 8 ARG D 87 THR D 91 5 5 HELIX 9 9 GLN E 219 GLU E 223 5 5 SHEET 1 AA 4 GLN A 3 SER A 7 0 SHEET 2 AA 4 LEU A 18 SER A 25 -1 O SER A 21 N SER A 7 SHEET 3 AA 4 THR A 78 MET A 83 -1 O LEU A 79 N CYS A 22 SHEET 4 AA 4 PHE A 68 ASP A 73 -1 O THR A 69 N GLN A 82 SHEET 1 AB 4 GLY A 10 VAL A 12 0 SHEET 2 AB 4 THR A 111 VAL A 115 -1 O MET A 112 N GLY A 10 SHEET 3 AB 4 ALA A 92 GLY A 100 -1 O ALA A 92 N VAL A 113 SHEET 4 AB 4 SER A 103 TRP A 107 -1 O SER A 103 N GLY A 100 SHEET 1 AC 6 GLY A 10 VAL A 12 0 SHEET 2 AC 6 THR A 111 VAL A 115 -1 O MET A 112 N GLY A 10 SHEET 3 AC 6 ALA A 92 GLY A 100 -1 O ALA A 92 N VAL A 113 SHEET 4 AC 6 MET A 34 GLN A 39 -1 O HIS A 35 N ALA A 97 SHEET 5 AC 6 LEU A 45 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AC 6 ILE A 58 TYR A 60 -1 O ASP A 59 N GLY A 50 SHEET 1 AD 2 SER A 103 TRP A 107 0 SHEET 2 AD 2 ALA A 92 GLY A 100 -1 O ARG A 98 N ASP A 105 SHEET 1 BA 4 LEU B 136 SER B 139 0 SHEET 2 BA 4 ALA B 151 ALA B 157 -1 O SER B 154 N SER B 139 SHEET 3 BA 4 ASP B 202 ILE B 207 -1 O PHE B 203 N CYS B 155 SHEET 4 BA 4 PHE B 194 SER B 199 -1 O THR B 195 N THR B 206 SHEET 1 BB 4 THR B 142 SER B 144 0 SHEET 2 BB 4 THR B 234 GLU B 237 1 O LYS B 235 N LEU B 143 SHEET 3 BB 4 ILE B 217 GLN B 222 -1 O TYR B 218 N THR B 234 SHEET 4 BB 4 THR B 229 PHE B 230 -1 O THR B 229 N GLN B 222 SHEET 1 BC 6 THR B 142 SER B 144 0 SHEET 2 BC 6 THR B 234 GLU B 237 1 O LYS B 235 N LEU B 143 SHEET 3 BC 6 ILE B 217 GLN B 222 -1 O TYR B 218 N THR B 234 SHEET 4 BC 6 LEU B 165 GLN B 170 -1 O ALA B 166 N GLN B 221 SHEET 5 BC 6 PRO B 176 SER B 181 -1 O ARG B 177 N GLN B 169 SHEET 6 BC 6 ASN B 185 ARG B 186 -1 O ASN B 185 N SER B 181 SHEET 1 BD 2 THR B 229 PHE B 230 0 SHEET 2 BD 2 ILE B 217 GLN B 222 -1 O GLN B 222 N THR B 229 SHEET 1 CA 4 GLY C 3 TYR C 4 0 SHEET 2 CA 4 ALA C 45 THR C 49 -1 O CYS C 48 N GLY C 3 SHEET 3 CA 4 GLY C 38 TYR C 42 -1 O GLY C 38 N THR C 49 SHEET 4 CA 4 GLY C 20 ASP C 21 -1 O GLY C 20 N CYS C 41 SHEET 1 DA 4 ASN D 3 SER D 7 0 SHEET 2 DA 4 LEU D 18 SER D 25 -1 O SER D 21 N SER D 7 SHEET 3 DA 4 THR D 78 MET D 83 -1 O LEU D 79 N CYS D 22 SHEET 4 DA 4 PHE D 68 ASP D 73 -1 O THR D 69 N GLN D 82 SHEET 1 DB 4 LEU D 11 VAL D 12 0 SHEET 2 DB 4 THR D 118 VAL D 122 -1 O THR D 121 N VAL D 12 SHEET 3 DB 4 ALA D 92 ASP D 99 -1 O ALA D 92 N VAL D 120 SHEET 4 DB 4 PHE D 111 TRP D 114 -1 N ASP D 112 O LYS D 98 SHEET 1 DC 6 LEU D 11 VAL D 12 0 SHEET 2 DC 6 THR D 118 VAL D 122 -1 O THR D 121 N VAL D 12 SHEET 3 DC 6 ALA D 92 ASP D 99 -1 O ALA D 92 N VAL D 120 SHEET 4 DC 6 MET D 34 GLN D 39 -1 O HIS D 35 N ALA D 97 SHEET 5 DC 6 LEU D 45 ILE D 51 -1 O GLU D 46 N ARG D 38 SHEET 6 DC 6 LYS D 58 TYR D 60 -1 O TYR D 59 N VAL D 50 SHEET 1 DD 2 PHE D 111 TRP D 114 0 SHEET 2 DD 2 ALA D 92 ASP D 99 -1 O LYS D 98 N ASP D 112 SHEET 1 EA 4 SER E 148 GLY E 151 0 SHEET 2 EA 4 THR E 244 VAL E 248 1 O LYS E 245 N ALA E 149 SHEET 3 EA 4 ASP E 225 ASP E 232 -1 O TYR E 226 N THR E 244 SHEET 4 EA 4 GLY E 237 PHE E 240 1 O GLY E 237 N ASP E 232 SHEET 1 EB 5 SER E 148 GLY E 151 0 SHEET 2 EB 5 THR E 244 VAL E 248 1 O LYS E 245 N ALA E 149 SHEET 3 EB 5 ASP E 225 ASP E 232 -1 O TYR E 226 N THR E 244 SHEET 4 EB 5 VAL E 173 HIS E 178 -1 O ASN E 174 N ALA E 229 SHEET 5 EB 5 GLU E 185 ILE E 188 -1 O GLU E 185 N ARG E 177 SHEET 1 EC 2 GLY E 237 PHE E 240 0 SHEET 2 EC 2 ASP E 225 ASP E 232 1 O ALA E 230 N VAL E 239 SHEET 1 ED 3 VAL E 157 SER E 162 0 SHEET 2 ED 3 SER E 210 ILE E 215 -1 O ALA E 211 N CYS E 161 SHEET 3 ED 3 PHE E 202 SER E 207 -1 O SER E 203 N ALA E 214 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 2 CYS B 155 CYS B 220 1555 1555 2.04 SSBOND 3 CYS C 12 CYS C 65 1555 1555 2.03 SSBOND 4 CYS C 16 CYS C 41 1555 1555 2.03 SSBOND 5 CYS C 25 CYS C 46 1555 1555 2.04 SSBOND 6 CYS C 29 CYS C 48 1555 1555 2.03 SSBOND 7 CYS D 22 CYS D 96 1555 1555 2.03 SSBOND 8 CYS D 103 CYS D 106 1555 1555 2.03 SSBOND 9 CYS E 161 CYS E 228 1555 1555 2.03 CISPEP 1 SER B 139 PRO B 140 0 -3.22 CISPEP 2 SER B 226 PRO B 227 0 -1.87 CISPEP 3 TRP C 58 PRO C 59 0 -3.64 CISPEP 4 SER E 190 HIS E 191 0 -15.58 CISPEP 5 ASN E 192 GLN E 193 0 -27.83 CISPEP 6 SER E 234 LEU E 235 0 8.37 CRYST1 45.576 74.643 140.239 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021941 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013397 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007131 0.00000